Healthy Skepticism Library item: 16765

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: news

Shire Subpoenaed In U.S. Drug Marketing Probe
The Wall Street Journal 2009 Oct 30
http://web.archive.org/web/20100124190008/http://online.wsj.com/article/BT-CO-20091030-713715.html

Abstract:

U.K. drug maker Shire PLC (SHP.LN) said Friday it has been subpoenaed by the U.S. authorities over the marketing of three drugs, as it reported a swing into profit for the third quarter.

Shire said, as part of its third-quarter results, that it received a subpoena Sept. 23 from the U.S. Department of Health and Human Services and the U.S. Attorney for the Eastern District of Pennsylvania, asking it for documents related to the sales and marketing of Adderall XR, Daytrana and Vyvanse, three drugs for attention deficit hyperactivity disorder, or ADHD.

Shire Chief …